Eugene Schneider, EVP, Chf Clinical Develop Ofcr at IONIS PHARMACEUTICALS INC (IONS), sold 2,826 shares at $40.67 ($115K) on 2023-02-06, disclosed to the SEC on 2023-02-07.
Open-market sale of $115k IONS by EVP, Chf Clinical Develop Ofcr. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.67 | 1,413 | $57K | 50.0% |
| 2 | $40.67 | 1,413 | $57K | 50.0% |
| Total | $40.67 avg | 2,826 | $115K | 100% |
| Filing → |
| IONS | SELL | 2026-02-02 | $516K | — | Filing → |
| IONS | SELL | 2026-01-20 | $703K | — | Filing → |
| IONS | SELL | 2025-09-04 | $2.4M | — | Filing → |